New era for ME/CFS research as top cytokine study attracts media headlines
The immune systems of patients who have recently developed ME/CFS look markedly different from those who have been ill for much longer, according to a major new study from Drs. Ian Lipkin and Mady Hornig at Columbia University. This shift in immune function hadn’t been seen before.
Discuss the article on the Forums.

Oxidative Stress May Be Target of New MS Drug

Discussion in 'Other Health News and Research' started by Gemini, Mar 28, 2013.

  1. Gemini

    Gemini Senior Member

    Messages:
    427
    Likes:
    409
    heapsreal likes this.
  2. SOC

    SOC Senior Member

    Messages:
    6,023
    Likes:
    9,341
    USA
    heapsreal likes this.
  3. Marco

    Marco Old blackguard

    Messages:
    1,650
    Likes:
    1,421
    Near Cognac, France
    For those interested, here's a little science on how dimethyl fumarate (DMF) may exert its neuroprotective effects :

    Effects of dimethyl fumarate on neuroprotection and immunomodulation

    http://www.jneuroinflammation.com/content/9/1/163
     
    Valentijn likes this.
  4. Waverunner

    Waverunner Senior Member

    Messages:
    1,000
    Likes:
    864
    What I never understood about oxidative stress and disease is the fact, that we already have thousands of anti-inflammatory substances. Most vitamins, minerals etc. are anti-inflammatory. So what's the difference between this new MS drug and other compounds? Does it address a special form of inflammation?
     
  5. Marco

    Marco Old blackguard

    Messages:
    1,650
    Likes:
    1,421
    Near Cognac, France
    What may be different is that it apparently stimulates the endogenous anti-inflammatory Nrf2 pathway.

    Some previous discussion on this thread :

    http://forums.phoenixrising.me/inde...oxidative-stress-increases-glutathione.19228/
     
  6. Gemini

    Gemini Senior Member

    Messages:
    427
    Likes:
    409
    Perhaps Tecfidera and the oxidative stress studies will be discussed at the April 25-6 FDA meeting?
     
  7. MishMash

    MishMash *****

    Messages:
    445
    Likes:
    487
    Georgia
    Basically, Biogen took a common psoriasis drug in Germany, Fumaderm, and "did something to it" so now they can sell it for fantastically high amounts. This is completely absurd. How they were able to get a patent for this is beyond me. People wonder why Medicare is bankrupting us, and no employers want to provide health insurance.

     
  8. Waverunner

    Waverunner Senior Member

    Messages:
    1,000
    Likes:
    864
    Yes, could be. I still don't get it however. Most drugs have anti-inflammatory effects. So do we just need a super-anti-inflammatory substance and everything will be fine for most diseases?
     

See more popular forum discussions.

Share This Page